We are live on ! Find out more
TC

Truvestments Capital Portfolio holdings

AUM $554M
1-Year Est. Return 32.49%
This Fund
S&P 500
This Quarter Est. Return
+7.38%
1 Year Est. Return
+32.49%
3 Year Est. Return
+86.71%
5 Year Est. Return
+90.42%
10 Year Est. Return
–
AUM
$201M
AUM Growth
+$13.3M
Cap. Flow
+$2.55M
Cap. Flow %
1.27%
Top 10 Hldgs %
19.35%
Holding
712
New
41
Increased
229
Reduced
120
Closed
19

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$329K
2
UNP icon
Union Pacific
UNP
+$202K
3
ABT icon
Abbott
ABT
+$194K
4
R icon
Ryder
R
+$164K
5
CVX icon
Chevron
CVX
+$158K

Top Sells

Rank Stock Value
1
TRTN
Triton International Limited
TRTN
+$3.64M
2
BWA icon
BorgWarner
BWA
+$300K
3
IBM icon
IBM
IBM
+$208K
4
AFCG
AFC Gamma
AFCG
+$197K
5
TA
TravelCenters of America LLC
TA
+$144K

Sector Composition

Rank Sector Weight
1 Technology 25.43%
2 Real Estate 18.25%
3 Industrials 12.28%
4 Healthcare 8.95%
5 Consumer Discretionary 7.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CFG icon
551
Citizens Financial Group
CFG
$30.5B
$3.76K ﹤0.01%
144
+69
+92% +$1.9K
KYMR icon
552
Kymera Therapeutics
KYMR
$8.88B
$3.75K ﹤0.01%
163
– –
CC icon
553
Chemours
CC
$2.23B
$3.69K ﹤0.01%
100
– –
CNDT icon
554
Conduent
CNDT
$240M
$3.68K ﹤0.01%
1,082
– –
DAVA icon
555
Endava
DAVA
$157M
$3.68K ﹤0.01%
71
– –
FPI
556
Farmland Partners
FPI
$418M
$3.66K ﹤0.01%
300
– –
WMB icon
557
Williams Companies
WMB
$86.8B
$3.62K ﹤0.01%
111
– –
PTGX icon
558
Protagonist Therapeutics
PTGX
$9.59B
$3.62K ﹤0.01%
131
– –
CBIO
559
Crescent Biopharma
CBIO
$643M
$3.58K ﹤0.01%
21
– –
RYTM icon
560
Rhythm Pharmaceuticals
RYTM
$7.95B
$3.56K ﹤0.01%
216
– –
TRTN
561
DELISTED
Triton International Limited
TRTN
$3.36K ﹤0.01%
40
-44,947
-100% -$3.64M
PLRX icon
562
Pliant Therapeutics
PLRX
$65M
$3.33K ﹤0.01%
184
– –
ILPT
563
Industrial Logistics Properties Trust
ILPT
$576M
$3.31K ﹤0.01%
1,004
+4
+0.4% +$9
PAYX icon
564
Paychex
PAYX
$42.9B
$3.24K ﹤0.01%
29
– –
SEDG icon
565
SolarEdge
SEDG
$1.98B
$3.23K ﹤0.01%
12
– –
TTC icon
566
Toro Company
TTC
$9.35B
$3.15K ﹤0.01%
31
– –
PBA icon
567
Pembina Pipeline
PBA
$27.7B
$3.14K ﹤0.01%
100
– –
RGP icon
568
Resources Connection
RGP
$148M
$3.14K ﹤0.01%
200
– –
IFN
569
Aberdeen India Fund
IFN
$506M
$3.11K ﹤0.01%
187
– –
RDFN
570
DELISTED
Redfin
RDFN
$3.1K ﹤0.01%
250
– –
CEG icon
571
Constellation Energy
CEG
$96.8B
$3.02K ﹤0.01%
33
– –
DBEF icon
572
Xtrackers MSCI EAFE Hedged Equity ETF
DBEF
$9.39B
$3.02K ﹤0.01%
85
+3
+4% +$108
PGEN icon
573
Precigen
PGEN
$2.55B
$2.96K ﹤0.01%
2,578
-1,000
-28% -$1.18K
DMRC icon
574
Digimarc Corp
DMRC
$169M
$2.94K ﹤0.01%
100
– –
JEPI icon
575
JPMorgan Equity Premium Income ETF
JEPI
$46B
$2.91K ﹤0.01%
53
+35
+194% +$1.91K
21 22
23
24 25

Similar funds

CA
Crossingbridge Advisors Pleasantville, New York $553M AUM 1.32% 1-Year Est. Return
SVCM
Saturn V Capital Management Austin, Texas $552M AUM 551.78% 1-Year Est. Return
CAM
Cander Asset Management New York $557M AUM
TC
Triata Capital Hong Kong $552M AUM 2.89% 1-Year Est. Return
BT
Brandywine Trust Hockessin, Delaware $552M AUM 5.23% 1-Year Est. Return
QL
Quarry LP New York $558M AUM 23.81% 1-Year Est. Return
IQI
Integrated Quantitative Investments Bellevue, Washington $551M AUM 45.27% 1-Year Est. Return
TCM
Thames Capital Management Roseland, New Jersey $558M AUM 236.21% 1-Year Est. Return

Truvestments Capital's Q2 2023 Portfolio in Review

As of Q2 2023, Truvestments Capital held 712 positions worth $201M, up 7.1% from $188M the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Truvestments Capital's Q2 2023 filing shows 41 new, 229 increased, 120 reduced and 19 closed positions. Its largest new stake was Ready Capital: 11,266 shares worth $127K. The largest sale was Triton International Limited, an estimated $3.64M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Real Estate and Industrials.

  • Truvestments Capital's largest Q2 2023 buy was Ready Capital: 11,266 shares worth $127K.
  • Truvestments Capital added most to Merck in Q2 2023, an estimated $329K increase.
  • Truvestments Capital's biggest Q2 2023 reduction was Triton International Limited, cutting an estimated $3.64M.
  • Truvestments Capital fully exited BorgWarner in Q2 2023, selling an estimated $300K.
  • Truvestments Capital's ten largest holdings make up 19% of its $201M portfolio in Q2 2023.
  • Truvestments Capital opened 41 new positions and closed 19 in Q2 2023.
  • Truvestments Capital's portfolio value rose 7.1% quarter-over-quarter to $201M.

Based on Truvestments Capital's 13F filing for Q2 2023, filed 10 Aug 2023.